Characteristics of coronary artery lesions in intravenous immunoglobulin - non - responsive kawasaki disease

Đặng Thị Hải Vân, Phạm Thảo Nguyên

Main Article Content

Abstract

The study was conducted to compare characteristics and progression of coronary artery lesions (CALs) between the intravenous immunoglobulin (IVIG) -responsive and non-responsive patients in 251 patients diagnosed with Kawasaki disease in Vietnam National Children’s Hospital. This was a prospective observational study. The research results notes that: among 251 patients included in the study, 35 patients were IVIG-non-responsive (13.9%). The IVIG-non-responsive patients experienced more sites of CALs at higher rates and severity than responsive patients (p < 0.05). After 6 months, 52.3% of patients who had CALs in acute phases recovered completely. The recovery rate of the IVIG- responsive group was significantly higher than that of the non-responsive group (61.2% versus 23.8%, p < 0.05). The patients’ ability to response to IVIG and the severity of CALs in acute phases influenced the ability to recover. This relationship alludes to the poor prognoses of patients with more severe CALs. In the CALs patients, C-reactive protein (CRP) levels before IVIG ≥ 119.4 mg/L and the neutrophil count before IVIG ≥ 10.4 G/L were independent risk factors for the IVIG- non-responsiveness.

Article Details

References

1. Kawasaki T. Kawasaki disease. Proc Jpn Acad Ser B Phys Biol Sci. 2006;82(2):59 - 71.
2. Newburger JW, takahashi M, burns JC. Kawasaki Disease. J Am Coll Cardiol. 2016;67(14):1738 - 1749. doi:10.1016/j.jacc.2015.12.073
3. Sano T, Kurotobi S, Matsuzaki K, et al. Prediction of non - responsiveness to standard high - dose gamma - globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr. 2006;166(2):131 - 137. doi:10.1007/s00431 - 006 - 0223 - z
4. Campbell AJ, burns JC. Adjunctive therapies for Kawasaki disease. J Infect. 2016;72:S1 - S5. doi:10.1016/j.jinf.2016.04.015
5. Xie T, Wang Y, Fu S, et al. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease. Pediatr Rheumatol Online J. 2017;15. doi:10.1186/s12969 - 017 - 0149 - 1
6. Kim BY, Kim D, Kim YH, et al. Non - Responders to Intravenous Immunoglobulin and Coronary Artery Dilatation in Kawasaki Disease: Predictive Parameters in Korean Children. Korean Circ J. 2016;46(4):542 - 549. doi:10.4070/kcj.2016.46.4.542
7. McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and Long - Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation. 2017;135(17). doi:10.1161/CIR.0000000000000484
8. Sluysmans T, Colan SD. Theoretical and empirical derivation of cardiovascular allometric relationships in children. J Appl Physiol Bethesda Md 1985. 2005;99(2):445 - 457. doi:10.1152/japplphysiol.01144.2004
9. Ronai C, Hamaoka - Okamoto A, baker AL, et al. Coronary Artery Aneurysm Measurement and Z Score Variability in Kawasaki Disease. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr. 2016;29(2):150 - 157. doi:10.1016/j.echo.2015.08.013
10. Rowley AH, Shulman ST. The Epidemiology and Pathogenesis of Kawasaki Disease. Front Pediatr. 2018;6. doi:10.3389/fped.2018.00374
11. Chbeir D, Gaschignard J, bonnefoy R, et al. Kawasaki disease: abnormal initial echocardiogram is associated with resistance to IV Ig and development of coronary artery lesions. Pediatr Rheumatol. 2018;16(1):48. doi:10.1186/s12969 - 018 - 0264 - 7
12. Azmoon S, Atkinson D, budoff MJ. Refractory progression of coronary aneurysms, a case of delayed onset Kawasaki disease as depicted by cardiac computed tomography angiography. Congenit Heart Dis. 2010;5(3):321 - 326. doi:10.1111/j.1747 - 0803.2009.00361.x
13. Newburger JW, takahashi M, Gerber MA, et al. Diagnosis, treatment, and Long - Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics. 2004;114(6):1708 - 1733. doi:10.1542/peds.2004 - 2182
14. Tremoulet AH, best BM, Song S, et al. Resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr. 2008;153(1):117 - 121. doi:10.1016/j.jpeds.2007.12.021
15. Terai M, Honda T, Yasukawa K, Higashi K, Hamada H, Kohno Y. Prognostic impact of vascular leakage in acute Kawasaki disease. Circulation. 2003;108(3):325 - 330. doi:10.1161/01.CIR.0000079166.93475.5F